natgillin/translations-raw huggingface dataset:
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore concluded that Tecfidera’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Tecfidera večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore concluded that the benefits of Oncaspar are greater than the risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Oncaspar večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore concluded that the benefits of Spectrila are greater than the risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Spectrila večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore concluded that Unituxin’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Unituxin večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Alprolix’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Alprolix večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Cabometyx’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Cabometyx večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Epclusa’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Epclusa večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Episalvan’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Episalvan večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Idelvion’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Idelvion večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Kisplyx’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Kisplyx večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Lartruvo’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Lartruvo večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Praxbind’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Praxbind večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Wakix’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Wakix večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Human Use (CHMP) therefore decided that Zepatier’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zato zaključil, da so koristi zdravila Zepatier večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Advocate’s benefits are greater than its risks and recommended that Advocate be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Advocate večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Aivlosin’s benefits are greater that its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Aivlosin večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Bravecto’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Bravecto večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that BTVPUR’s benefits are greater that its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila BTVPUR večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Canigen L4’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Canigen L4 večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Clomicalm’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Clomicalm večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Draxxin’s benefits are greater than its risks and recommended that it be approved in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Draxxin večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Eravac’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Eravac večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Evalon’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Evalon večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Imrestor’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Imrestor večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Innovax- ILT’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Innovax-ILT večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Letifend’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Letifend večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Metacam’s benefits are greater than its risks and they recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Metacam večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that MS-H Vaccine’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi cepiva MS-H večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Porcilis PCV ID’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Porcilis PCV ID večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Poulvac E. coli’s benefits are greated that its risks and recommended that it be approved in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Poulvac E. coli večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Profender’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Profender večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Reconcile’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Reconcile večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that SevoFlo’s benefits are greater that its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila SevoFlo večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Simparica’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Simparica večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Suvaxyn Circo+MH RTU’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Suvaxyn Circo+MH RTU večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that UpCard’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila UpCard večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Vectormune ND’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Vectormune ND večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Velactis’ benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Velactis večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that ZACTRAN’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila ZACTRAN večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Zulvac SBV’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Zulvac CBV večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that Zycortal’s benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Zycortal večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that, in accordance with EU requirements, Inflacam has been shown to have comparable quality and to be bioequivalent to Metacam.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Inflacam primerljivo raven kakovosti kot zdravilo Metacam ter da mu je biološko enakovredno.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that, in accordance with EU requirements, Novaquin has been shown to have comparable quality and to be bioequivalent to Metacam.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Novaquin primerljivo raven kakovosti kot zdravilo Metacam ter da mu je biološko enakovredno.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that, in accordance with EU requirements, Sedadex has been shown to have comparable quality to Dexdomitor.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da je bilo v skladu z zahtevami EU dokazano, da ima zdravilo Sedadex primerljivo raven kakovosti kot zdravilo Dexdomitor.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) concluded that, in accordance with EU requirements, Sevohale has been shown to be comparable to SevoFlo.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da je bilo v skladu z zahtevami EU dokazano, da je zdravilo Sevohale primerljivo z zdravilom SevoFlo.
The Agency’s Committee for Medicinal Products for Veterinary Use (CVMP) decided that Fortekor Plus’ benefits are greater than its risks and recommended that it be approved for use in the EU.
Odbor za zdravila za uporabo v veterinarski medicini (CVMP) pri agenciji je zaključil, da so koristi zdravila Fortekor Plus večje od z njim povezanih tveganj, in priporočil, da se odobri za uporabo v EU.
The Agenerase oral solution contains 15 mg/ml of amprenavir.
Peroralna raztopina Agenerase vsebuje 15 mg/ml amprenavirja.
The agreement rate for the image obtained with Rapiscan or adenosine relative to the initial adenosine image was calculated by determining how frequently the patients assigned to each initial adenosine category (0-1, 2-4, 5-17 reversible segments) were placed in the same category with the randomised scan.
Stopnja ujemanja za posnetke, pridobljene z zdravilom Rapiscan ali z adenozinom v primerjavi z začetnim posnetkom z adenozinom, je bila izračunana tako, da se je ugotovilo, kako pogosto so bili bolniki, ki so bili uvrščeni v začetno kategorijo adenozina (0-1, 2-4, 5-17 reverzibilni segmenti) z randomiziranim slikanjem uvrščeni v enako kategorijo.
The agreement rate was 83%.
Stopnja ujemanja je bila 83 %.
The agreement rates for Rapiscan and adenosine were calculated as the average of the agreement rates across the three categories determined by the initial scan.
Stopnje ujemanja za zdravilo Rapiscan in adenozin so bile izračunane kot povprečje stopenj ujemanja za vse tri kategorije, ugotovljene z začetnim slikanjem.
The aim is to implement similar wording across all products concerned to optimize risk minimisation and ensure consistency in information provided to patients.
Cilj je, da bo besedilo za vsa zadevna zdravila podobno, da bo tveganje v največji možni meri zmanjšano in da bo zagotovljena skladnost informacij, ki jih dobijo bolniki.
The aim of Rienso therapy is to replenish the body’s iron stores.
Cilj zdravljenja z zdravilom Rienso je napolniti zaloge železa v telesu.
The aim of the study was to assess efficacy, safety, and tolerability of Ilaris (150 mg or 2 mg/kg every 8 weeks) in patients with CAPS.
Namen študije je bil oceniti učinkovitost, varnost in prenašanje zdravila Ilaris (150 mg oziroma 2 mg/kg vsakih 8 tednov) pri bolnikih s CAPS.
The aim of the treatment initiation form is to protect patients and any possible foetuses by ensuring that patients are fully informed of and understand the risk of teratogenicity and other adverse reactions associated with the use of thalidomide.
Cilj obrazca za začetek zdravljenja je zaščititi bolnike in morebitne plode tako, da se zagotovi popolna obveščenost in razumevanje bolnikov glede tveganja teratogenosti in drugih neželenih učinkov, povezanih z uporabo talidomida.
The aim of the treatment is to keep blood levels of homocysteine below 15 micromoles or as low as possible.
Namen zdravljenja je vzdrževanje ravni homocisteina pod 15 mikromolov ali na čim manjši vrednosti.
The aim of this part of the study was to assess whether treatment with Ilaris allowed a reduction in the use of steroids in at least a quarter of patients.
Namen tega dela študije je bil oceniti, ali se je zaradi zdravljenja z zdravilom Ilaris zmanjšala uporaba steroidov pri vsaj četrtini bolnikov.
The airless pump allows the product to be administered whatever the position of the bottle is.
Brezzračna črpalka dovoljuje dajanje zdravila ne glede na položaj črpalke.
The albumin-bound fraction and the unbound fraction are collectively termed ‘bioavailable’ testosterone.
Delež, vezan na albumin, in nevezan delež skupaj sestavljata “biološko uporaben” testosteron.
The alendronate component in the FOSAVANCE (70 mg/2,800 IU) combination tablet is bioequivalent to the alendronate 70 mg tablet.
Alendronat v kombinirani tableti FOSAVANCE (70 mg/2.800 i.e.) je bioekvivalenten alendronatu v 70 mg tableti.
The alendronate component in the FOSAVANCE (70 mg/5,600 IU) combination tablet is bioequivalent to the alendronate 70 mg tablet.
Alendronat v kombinirani tableti FOSAVANCE (70 mg/5.600 i.e.) je bioekvivalenten alendronatu v 70 mg tableti.
The alendronate component in the VANTAVO (70 mg/2800 IU) combination tablet is bioequivalent to the alendronate 70 mg tablet.
Alendronat v kombinirani tableti VANTAVO (70 mg/2.800 i.e.) je bioekvivalenten alendronatu v 70 mg tableti.
The alendronate component in the VANTAVO (70 mg/5600 IU) combination tablet is bioequivalent to the alendronate 70 mg tablet.
Alendronat v kombinirani tableti VANTAVO (70 mg/5.600 i.e.) je bioekvivalenten alendronatu v 70 mg tableti.
The alpha particle range from radium-223 is less than 100 micrometers (less than 10 cell diameters) which minimises damage to the surrounding normal tissue.
Doseg delcev alfa iz [223Ra] je manjši od 100 mikrometrov (manjši od 10-kratnika premera celice), kar zmanjša poškodbe na normalnem okolnem tkivu na najmanjšo možno mero.
The alterations were not considered clinically relevant, since pharmacodynamic effects based on bone turnover markers were consistent across a wide range of body weight.
Teh sprememb niso ocenili za klinično pomembne, ker so bili farmakodinamski učinki, ocenjeni z označevalci presnove kostnega tkiva, podobni pri zelo različnih telesnih masah.
The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03 and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component (see scheme).
Za ohranjanje ravni imunosti proti influenci konjev priporočamo izmenično uporabo, v razmikih po 12 mesecev, ustreznega cepiva proti influenci konj, ki vsebuje seve A/konjski- 2/Južna Afrika/4/03 in A/konjski 2/Newmarket-2/93 (glejte shemo).
The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03 and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component (see scheme).
Za ohranjanje ravni imunosti proti influenci konjev priporočamo izmenično uporabo, v razmikih po 12 mesecev, ustreznega cepiva proti influenci konj, ki vsebuje seve A/konjski- 2/Južna Afrika/4/03 in A/konjski-2/Newmarket-2/93 (glejte shemo).
The alternate use, at 12 months interval, of a suitable vaccine against equine influenza, containing the strains A/equine-2/South Africa/4/03and A/equine-2/Newmarket-2/93, is recommended to maintain immunity levels for the influenza component (see scheme).
Za ohranjanje ravni imunosti proti influenci konjev priporočamo izmenično uporabo, v razmikih po 12 mesecev, ustreznega cepiva proti influenci konj, ki vsebuje seve A/konjski-2/Južna Afrika/4/03, A/konjski-2/Newmarket-2/93 (glejte shemo).